The Claim
Creatine monohydrate supplementation does not significantly improve depressive symptoms in adolescent females with major depressive disorder who are already taking SSRIs, despite increasing frontal lobe phosphocreatine concentrations.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adolescent females with major depressive disorder taking SSRIs, creatine monohydrate supplementation does not reduce depressive symptoms, even though it increases phosphocreatine levels in the frontal lobe.
See the scientific wording
Creatine monohydrate supplementation does not significantly improve depressive symptoms in adolescent females with major depressive disorder who are already taking SSRIs, despite increasing frontal lobe phosphocreatine concentrations.
Creatine increases the brain's energy reserve in the frontal lobe, but when antidepressants are already boosting serotonin, this extra energy does not change how mood-related brain circuits function.
What the research says
1 studyIn teenage girls with depression who are already taking antidepressants, taking creatine daily for eight weeks didn’t make them feel better than taking a sugar pill — even though it changed a brain energy marker. So the study agrees with the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.